<VariationArchive VariationID="2960869" VariationName="NM_001182.5(ALDH7A1):c.621_624del (p.Ile207_Ala208insTer)" VariationType="Deletion" Accession="VCV002960869" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-05" DateCreated="2024-02-29" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3123371" VariationID="2960869">
      <GeneList>
        <Gene Symbol="ALDH7A1" FullName="aldehyde dehydrogenase 7 family member A1" GeneID="501" HGNC_ID="HGNC:877" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5q23.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="126541841" stop="126595219" display_start="126541841" display_stop="126595219" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="125877532" stop="125931081" display_start="125877532" display_stop="125931081" Strand="-" />
          </Location>
          <OMIM>107323</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001182.5(ALDH7A1):c.621_624del (p.Ile207_Ala208insTer)</Name>
      <CanonicalSPDI>NC_000005.10:126577104:GGCG:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>5q23.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="126577105" stop="126577108" display_start="126577105" display_stop="126577108" variantLength="4" positionVCF="126577104" referenceAlleleVCF="TGGCG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="125912797" stop="125912800" display_start="125912797" display_stop="125912800" variantLength="4" positionVCF="125912796" referenceAlleleVCF="TGGCG" alternateAlleleVCF="T" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.126577105_126577108del" Assembly="GRCh38">
            <Expression>NC_000005.10:g.126577105_126577108del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.125912797_125912800del" Assembly="GRCh37">
            <Expression>NC_000005.9:g.125912797_125912800del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008600.3" sequenceAccession="NG_008600" sequenceVersion="3" change="g.23283_23286del">
            <Expression>NG_008600.3:g.23283_23286del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001182.5" sequenceAccession="NM_001182" sequenceVersion="5" change="c.621_624del" MANESelect="true">
            <Expression>NM_001182.5:c.621_624del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001173.2" sequenceAccession="NP_001173" sequenceVersion="2" change="p.Ile207_Ala208insTer">
            <Expression>NP_001173.2:p.Ile207_Ala208insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001201377.2" sequenceAccession="NM_001201377" sequenceVersion="2" change="c.537_540del">
            <Expression>NM_001201377.2:c.537_540del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001188306.1" sequenceAccession="NP_001188306" sequenceVersion="1" change="p.Ile179_Ala180insTer">
            <Expression>NP_001188306.1:p.Ile179_Ala180insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001202404.2" sequenceAccession="NM_001202404" sequenceVersion="2" change="c.621_624del">
            <Expression>NM_001202404.2:c.621_624del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001189333.2" sequenceAccession="NP_001189333" sequenceVersion="2" change="p.Ile207_Ala208insTer">
            <Expression>NP_001189333.2:p.Ile207_Ala208insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001182.5(ALDH7A1):c.621_624del (p.Ile207_Ala208insTer) AND Pyridoxine-dependent epilepsy" Accession="RCV003817604" Version="1">
        <ClassifiedConditionList TraitSetID="6038">
          <ClassifiedCondition DB="MedGen" ID="C1849508">Pyridoxine-dependent epilepsy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-10-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-10-07" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-02-29" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16491085</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20554659</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6038" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1615" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Pyridoxine-Dependent Seizures</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Pyridoxine-dependent epilepsy</ElementValue>
                <XRef ID="Pyridoxine-dependent+epilepsy/6116" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009945" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPILEPSY, EARLY-ONSET, 4, VITAMIN B6-DEPENDENT</ElementValue>
                <XRef Type="MIM" ID="266100" DB="OMIM" />
                <XRef Type="Allelic variant" ID="107323.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="107323.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="107323.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="107323.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="107323.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="107323.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="107323.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="107323.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="107323.0007" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pyridoxine dependency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pyridoxine dependency with seizures</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Vitamin B6-dependent seizures</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">EPD</ElementValue>
                <XRef Type="MIM" ID="266100" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">EPEO4</ElementValue>
                <XRef Type="MIM" ID="266100" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PDE</ElementValue>
                <XRef Type="MIM" ID="266100" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ALDH7A1 deficiency</ElementValue>
                <XRef ID="GTR000328761" DB="Genetic Testing Registry (GTR)" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Pyridoxine-Dependent Epilepsy - ALDH7A1</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9298" />
                <XRef ID="9298" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Pyridoxine-dependent epilepsy â€“ ALDH7A1 (PDE-ALDH7A1) is characterized by seizures not well controlled with anti-seizure medication that are responsive clinically and electrographically to large daily supplements of pyridoxine (vitamin B6). This is true across a phenotypic spectrum that ranges from classic to atypical PDE-ALDH7A1. Intellectual disability is common, particularly in classic PDE-ALDH7A1. Classic PDE-ALDH7A1. Untreated seizures begin within the first weeks to months of life. Dramatic presentations of prolonged seizures and recurrent episodes of status epilepticus are typical; recurrent self-limited events including partial seizures, generalized seizures, atonic seizures, myoclonic events, and infantile spasms also occur. Electrographic seizures can occur without clinical correlates. Atypical PDE-ALDH7A1. Findings in untreated individuals can include late-onset seizures beginning between late infancy and age three years, seizures that initially respond to anti-seizure medication and then become intractable, seizures during early life that do not respond to pyridoxine but are subsequently controlled with pyridoxine several months later, and prolonged seizure-free intervals (=5 months) that occur after discontinuation of pyridoxine.</Attribute>
                <XRef ID="NBK1486" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000509482" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500153" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520979" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520995" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000593378" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000318883" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515787" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520980" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551668" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301659</ID>
                <ID Source="BookShelf">NBK1486</ID>
              </Citation>
              <XRef ID="3006" DB="Orphanet" />
              <XRef ID="C1849508" DB="MedGen" />
              <XRef ID="MONDO:0009945" DB="MONDO" />
              <XRef Type="MIM" ID="266100" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8573640" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2024-02-28">
        <ClinVarSubmissionID localKey="12148043|MedGen:C1849508" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004617582" DateUpdated="2024-02-28" DateCreated="2024-02-28" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16491085</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20554659</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ala208*) in the ALDH7A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ALDH7A1 are known to be pathogenic (PMID: 16491085, 20554659). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with ALDH7A1-related conditions. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ALDH7A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000005.9:g.125912797_125912800del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1849508" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8573640" TraitType="Disease" MappingType="XRef" MappingValue="C1849508" MappingRef="MedGen">
        <MedGen CUI="C1849508" Name="Pyridoxine-dependent epilepsy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

